Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viking Therapeutics (VKTX) Treasury Shares (2016 - 2023)

Historic Treasury Shares for Viking Therapeutics (VKTX) over the last 10 years, with Q4 2023 value amounting to $2.2 million.

  • Viking Therapeutics' Treasury Shares rose 1737.92% to $2.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was $2.2 million, marking a year-over-year increase of 1737.92%. This contributed to the annual value of $2.2 million for FY2023, which is 0.0% changed from last year.
  • Latest data reveals that Viking Therapeutics reported Treasury Shares of $6.8 million as of Q4 2023, which was down 0.0% from $6.8 million recorded in Q3 2023.
  • Viking Therapeutics' 5-year Treasury Shares high stood at $2.2 million for Q2 2022, and its period low was $352726.0 during Q4 2019.
  • Over the past 5 years, Viking Therapeutics' median Treasury Shares value was $1.0 million (recorded in 2021), while the average stood at $1.3 million.
  • Within the past 5 years, the most significant YoY rise in Viking Therapeutics' Treasury Shares was 3268.89% (2023), while the steepest drop was 0.0% (2023).
  • Viking Therapeutics' Treasury Shares (Quarter) stood at $6.8 million in 2022, then changed by 0.0% to $6.8 million in 2023.
  • Its Treasury Shares stands at $2.2 million for Q4 2023, versus $2.2 million for Q3 2023 and $2.2 million for Q2 2023.